Qure.ai, a healthcare startup that is propelled by AI, has secured $65 million in its Series D funding round. Merck Global Health Innovation Fund and Kae Capital participated in the round, which was led by 360 ONE Asset and Lightspeed.
Novo Holdings, Health Quad, and TeamFund, the company’s existing investors, also participated in the round, according to a statement. Qure.ai intends to leverage the funding to expedite its expansion into the United States and other global markets.
It also plans to increase funding for the development of foundational AI models and the enhancement of its technology base. Furthermore, the investment will allow Qure.ai to pursue strategic acquisitions of complementary MedTech companies, thereby further solidifying its position in the healthcare AI industry.
Read also – HomeLane to Acquire Design Cafe and Raises Rs 225 Cr Funding
Qure.ai has significantly expanded its market presence. Its AI-driven healthcare solutions are currently deployed in over 90 countries, with 3,000+ sites. Qure.ai, which is headquartered in Mumbai, has regional offices in New York, London, and Dubai, thereby enhancing its global presence.
The company is a specialist in the identification and management of critical diseases, with 18 FDA-cleared indications and Class IIb certification under EU MDR regulations.
Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:
Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.
Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.
Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.
